LivingGLP1
Study S000788

GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

Registration

Registration
NCT01451905
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
QUADRUPLE
Status
UNKNOWN
Enrollment
12
Start
2011-08
Primary completion
2012-12
Lead sponsor
University Hospital, Gentofte, Copenhagen
Conditions
Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI
Interventions
DRUG:Liraglutide; DRUG:Placebo
Results posted
FALSE

Registered primary outcomes

  • Changes in PASI and DLQI [2 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.